TechSchenlab Launches with TÜBİTAK-BİGG-1812 Support for Revolutionary Diabetes Technology

We are excited to announce the official launch of TechSchenlab Technology Inc., operating under Teknopark İSTE A.Ş., with an ambitious mission: to redefine health technology. Our journey began with the prestigious TÜBİTAK-BİGG-1812 grant, awarded to our Chairman of the Board, Fikret Alpay Tekşen, for the groundbreaking project "Non-Invasive Blood Glucose Sensor."

A Game-Changer in Blood Glucose Monitoring

Traditional blood glucose monitoring methods are often invasive, requiring finger pricks or other uncomfortable procedures that can be inconvenient and painful for users. Our innovative device, however, will utilize microwave sensor technology to measure blood glucose levels directly and painlessly—without piercing the skin.

This non-invasive approach aims to:

• Enhance the quality of life for people with diabetes.

• Make daily glucose monitoring more comfortable and user-friendly.

• Reduce the long-term burden of invasive testing methods.

Why It Matters?

Diabetes management depends heavily on consistent and accurate monitoring. By removing the discomfort and hassle from this process, we can empower patients to monitor their health more regularly—leading to better control, fewer complications, and healthier lives.

Paving the Way for Commercialization

With the TÜBİTAK-BİGG-1812 support, TechSchenlab has taken a major step toward commercialization of this groundbreaking technology. Our vision is to not only address the needs of diabetes patients in Turkey but also to introduce a world-class, locally developed solution to the global healthcare market.

This project represents a significant contribution to Turkey’s vision for developing domestic and national technologies, setting a new benchmark for diabetes care.

We thank TÜBİTAK for their support and remain committed to developing innovative healthcare solutions that make a real difference—today and in the future.